US Stock MarketDetailed Quotes

TARA Protara Therapeutics

Watchlist
  • 2.050
  • +0.070+3.54%
Close Aug 15 16:00 ET
  • 2.050
  • 0.0000.00%
Post 20:02 ET
42.29MMarket Cap-676P/E (TTM)

Protara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
18.29%-7.69M
19.47%-10.38M
-41.95%-37.56M
-73.10%-8.7M
-22.70%-6.56M
-83.64%-9.41M
-17.58%-12.89M
23.32%-26.46M
27.23%-5.03M
13.77%-5.35M
Net income from continuing operations
15.77%-9.51M
-22.66%-11.1M
38.71%-40.42M
73.77%-10.22M
-28.20%-9.86M
-32.26%-11.29M
15.90%-9.05M
-39.58%-65.95M
-280.98%-38.97M
28.64%-7.69M
Depreciation and amortization
6.41%83K
7.79%83K
37.50%341K
42.67%107K
23.44%79K
47.17%78K
37.50%77K
111.97%248K
111.40%75K
-90.70%64K
Other non cash items
-26.90%250K
-27.86%246K
-25.84%1.01M
-11.70%302K
-91.79%28K
0.00%342K
0.00%341K
30.10%1.37M
--342K
--341K
Change In working capital
2,394.74%436K
86.63%-771K
-867.90%-4.14M
-109.19%-227K
717.47%1.87M
-102.59%-19K
-99.34%-5.77M
204.46%539K
337.77%2.47M
-64.16%229K
-Change in prepaid assets
-98.61%57K
107.08%435K
-577.36%-1.27M
-6.30%654K
-55.83%125K
772.55%4.1M
-418.13%-6.15M
163.40%265K
273.26%698K
-77.23%283K
-Change in payables and accrued expense
107.50%112K
-201.68%-665K
-75.13%343K
-131.96%-643K
808.46%1.83M
-341.75%-1.49M
145.04%654K
123.86%1.38M
237.02%2.01M
3,920.00%201K
-Change in other current assets
122.22%510K
-618.97%-301K
-1,136.04%-2.3M
-103.30%-3K
-177.92%-60K
-9,462.50%-2.3M
-25.64%58K
-24.75%222K
10.98%91K
123.19%77K
-Change in other current liabilities
26.59%-243K
27.71%-240K
30.90%-917K
29.22%-235K
94.28%-19K
0.00%-331K
0.00%-332K
-31.52%-1.33M
-9.93%-332K
-19.86%-332K
Cash from discontinued investing activities
Operating cash flow
18.29%-7.69M
19.47%-10.38M
-41.95%-37.56M
-73.10%-8.7M
-22.70%-6.56M
-83.64%-9.41M
-17.58%-12.89M
23.32%-26.46M
27.23%-5.03M
13.77%-5.35M
Investing cash flow
Cash flow from continuing investing activities
-86.82%2.95M
134.28%23.1M
255.23%53.11M
179.14%14.52M
-66.52%6.38M
65.54%22.35M
1,223.49%9.86M
115.22%14.95M
-1,071.15%-18.35M
17,701.87%19.05M
Net PPE purchase and sale
-2,650.00%-55K
--0
62.50%-45K
--0
55.42%-37K
90.00%-2K
45.45%-6K
79.87%-120K
86.36%-6K
-229.69%-83K
Net investment purchase and sale
-86.58%3M
134.14%23.1M
252.70%53.15M
179.16%14.52M
-66.47%6.42M
65.31%22.35M
1,205.03%9.87M
115.44%15.07M
-1,048.73%-18.34M
44,390.70%19.13M
Cash from discontinued investing activities
Investing cash flow
-86.82%2.95M
134.28%23.1M
255.23%53.11M
179.14%14.52M
-66.52%6.38M
65.54%22.35M
1,223.49%9.86M
115.22%14.95M
-1,071.15%-18.35M
17,701.87%19.05M
Financing cash flow
Cash flow from continuing financing activities
42.09M
-18.75%-76K
-1.11%-91K
0
-50.00%-27K
0
11.11%-64K
60.53%-90K
0
-18K
Net common stock issuance
65,587.50%42.04M
-18.75%-76K
-1.11%-91K
--0
-405.56%-91K
--64K
11.11%-64K
60.53%-90K
--0
---18K
Cash from discontinued financing activities
Financing cash flow
--42.09M
-18.75%-76K
-1.11%-91K
--0
-50.00%-27K
--0
11.11%-64K
60.53%-90K
--0
---18K
Net cash flow
Beginning cash position
143.23%52.98M
62.15%40.33M
-31.80%24.87M
-28.46%34.51M
0.47%34.72M
-16.81%21.78M
-31.80%24.87M
-78.47%36.47M
16.28%48.24M
-27.37%34.56M
Current changes in cash
188.57%37.35M
508.96%12.65M
233.30%15.46M
124.89%5.82M
-101.53%-210K
54.47%12.94M
69.95%-3.09M
91.28%-11.6M
-365.74%-23.37M
324.53%13.68M
End cash Position
160.13%90.33M
143.23%52.98M
62.15%40.33M
62.15%40.33M
-28.46%34.51M
0.47%34.72M
-16.81%21.78M
-31.80%24.87M
-31.80%24.87M
16.28%48.24M
Free cash flow
17.73%-7.74M
19.51%-10.38M
-41.48%-37.6M
-72.89%-8.7M
-21.51%-6.6M
-82.97%-9.41M
-17.52%-12.89M
24.28%-26.58M
27.61%-5.03M
11.52%-5.43M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 18.29%-7.69M19.47%-10.38M-41.95%-37.56M-73.10%-8.7M-22.70%-6.56M-83.64%-9.41M-17.58%-12.89M23.32%-26.46M27.23%-5.03M13.77%-5.35M
Net income from continuing operations 15.77%-9.51M-22.66%-11.1M38.71%-40.42M73.77%-10.22M-28.20%-9.86M-32.26%-11.29M15.90%-9.05M-39.58%-65.95M-280.98%-38.97M28.64%-7.69M
Depreciation and amortization 6.41%83K7.79%83K37.50%341K42.67%107K23.44%79K47.17%78K37.50%77K111.97%248K111.40%75K-90.70%64K
Other non cash items -26.90%250K-27.86%246K-25.84%1.01M-11.70%302K-91.79%28K0.00%342K0.00%341K30.10%1.37M--342K--341K
Change In working capital 2,394.74%436K86.63%-771K-867.90%-4.14M-109.19%-227K717.47%1.87M-102.59%-19K-99.34%-5.77M204.46%539K337.77%2.47M-64.16%229K
-Change in prepaid assets -98.61%57K107.08%435K-577.36%-1.27M-6.30%654K-55.83%125K772.55%4.1M-418.13%-6.15M163.40%265K273.26%698K-77.23%283K
-Change in payables and accrued expense 107.50%112K-201.68%-665K-75.13%343K-131.96%-643K808.46%1.83M-341.75%-1.49M145.04%654K123.86%1.38M237.02%2.01M3,920.00%201K
-Change in other current assets 122.22%510K-618.97%-301K-1,136.04%-2.3M-103.30%-3K-177.92%-60K-9,462.50%-2.3M-25.64%58K-24.75%222K10.98%91K123.19%77K
-Change in other current liabilities 26.59%-243K27.71%-240K30.90%-917K29.22%-235K94.28%-19K0.00%-331K0.00%-332K-31.52%-1.33M-9.93%-332K-19.86%-332K
Cash from discontinued investing activities
Operating cash flow 18.29%-7.69M19.47%-10.38M-41.95%-37.56M-73.10%-8.7M-22.70%-6.56M-83.64%-9.41M-17.58%-12.89M23.32%-26.46M27.23%-5.03M13.77%-5.35M
Investing cash flow
Cash flow from continuing investing activities -86.82%2.95M134.28%23.1M255.23%53.11M179.14%14.52M-66.52%6.38M65.54%22.35M1,223.49%9.86M115.22%14.95M-1,071.15%-18.35M17,701.87%19.05M
Net PPE purchase and sale -2,650.00%-55K--062.50%-45K--055.42%-37K90.00%-2K45.45%-6K79.87%-120K86.36%-6K-229.69%-83K
Net investment purchase and sale -86.58%3M134.14%23.1M252.70%53.15M179.16%14.52M-66.47%6.42M65.31%22.35M1,205.03%9.87M115.44%15.07M-1,048.73%-18.34M44,390.70%19.13M
Cash from discontinued investing activities
Investing cash flow -86.82%2.95M134.28%23.1M255.23%53.11M179.14%14.52M-66.52%6.38M65.54%22.35M1,223.49%9.86M115.22%14.95M-1,071.15%-18.35M17,701.87%19.05M
Financing cash flow
Cash flow from continuing financing activities 42.09M-18.75%-76K-1.11%-91K0-50.00%-27K011.11%-64K60.53%-90K0-18K
Net common stock issuance 65,587.50%42.04M-18.75%-76K-1.11%-91K--0-405.56%-91K--64K11.11%-64K60.53%-90K--0---18K
Cash from discontinued financing activities
Financing cash flow --42.09M-18.75%-76K-1.11%-91K--0-50.00%-27K--011.11%-64K60.53%-90K--0---18K
Net cash flow
Beginning cash position 143.23%52.98M62.15%40.33M-31.80%24.87M-28.46%34.51M0.47%34.72M-16.81%21.78M-31.80%24.87M-78.47%36.47M16.28%48.24M-27.37%34.56M
Current changes in cash 188.57%37.35M508.96%12.65M233.30%15.46M124.89%5.82M-101.53%-210K54.47%12.94M69.95%-3.09M91.28%-11.6M-365.74%-23.37M324.53%13.68M
End cash Position 160.13%90.33M143.23%52.98M62.15%40.33M62.15%40.33M-28.46%34.51M0.47%34.72M-16.81%21.78M-31.80%24.87M-31.80%24.87M16.28%48.24M
Free cash flow 17.73%-7.74M19.51%-10.38M-41.48%-37.6M-72.89%-8.7M-21.51%-6.6M-82.97%-9.41M-17.52%-12.89M24.28%-26.58M27.61%-5.03M11.52%-5.43M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg